title: Genetic variability in the myostatin gene does not explain the muscle hypertrophy and clinical penetrance in myotonia congenita.
authors.forename: Viviane P
authors.initials: VP
authors.lastname: Muniz
authors.forename: Adriano S
authors.initials: AS
authors.lastname: Senkevics
authors.forename: Dinorah
authors.initials: D
authors.lastname: Zilbersztajn
authors.forename: Juliana
authors.initials: J
authors.lastname: Gurgel-Giannetti
authors.forename: Helga C
authors.initials: HC
authors.lastname: Silva
authors.forename: Lydia U
authors.initials: LU
authors.lastname: Yamamoto
authors.forename: Rita C M
authors.initials: RC
authors.lastname: Pavanello
authors.forename: Peter L
authors.initials: PL
authors.lastname: Pearson
authors.forename: Mayana
authors.initials: M
authors.lastname: Zatz
authors.forename: Mariz
authors.initials: M
authors.lastname: Vainzof
mesh_terms: D018118:Chloride Channels / Q000235:genetics; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation / Q000235:genetics*; D006801:Humans; D006984:Hypertrophy / Q000235:genetics* / Q000473:pathology; D018908:Muscle Weakness / Q000235:genetics; D018482:Muscle, Skeletal / Q000473:pathology*; D009154:Mutation; D055435:Myostatin / Q000235:genetics*; D009224:Myotonia Congenita / Q000235:genetics* / Q000473:pathology; D010375:Pedigree; D019683:Penetrance
chemical_list: C086321:CLC-1 channel; D018118:Chloride Channels; D055435:Myostatin